GCIA
NKGNW

Gabelli & Co Investment Advisers’s NKGen Biotech, Inc. Warrants NKGNW Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio NKGNW Stock Details NKGNW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-17,240
Closed -$1.72K – 276
2024
Q4 		$1.72K Hold
17,240
– – ﹤0.01% 240
2024
Q3 		$1.22K Hold
17,240
– – ﹤0.01% 211
2024
Q2 		$1.5K Hold
17,240
– – ﹤0.01% 249
2024
Q1 		$2.76K Hold
17,240
– – ﹤0.01% 234
2023
Q4 		$1.39K Buy
+17,240
New +$2.33K ﹤0.01% 232
2023
Q3 		– Sell
-17,240
Closed -$3.45K – 269
2023
Q2 		$3.45K Hold
17,240
– – ﹤0.01% 229
2023
Q1 		$2.42K Hold
17,240
– – ﹤0.01% 216
2022
Q4 		$1.46K Hold
17,240
– – ﹤0.01% 264
2022
Q3 		$3K Hold
17,240
– – ﹤0.01% 402
2022
Q2 		$4K Hold
17,240
– – ﹤0.01% 433
2022
Q1 		$10K Hold
17,240
– – ﹤0.01% 449
2021
Q4 		$20K Hold
17,240
– – ﹤0.01% 442
2021
Q3 		$20K Buy
+17,240
New +$21.5K ﹤0.01% 441

Other funds holding NKGNW

RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.79% 1-Year Est. Return
MTCM
Mint Tower Capital Management Amsterdam, Netherlands $1.12B AUM 18.84% 1-Year Est. Return

Gabelli & Co Investment Advisers's NKGNW Position: Q1 2025 in Review

Gabelli & Co Investment Advisers sold out of NKGen Biotech, Inc. Warrants (NKGNW) in Q1 2025, closing a stake of 17,240 shares — an estimated $1.72K sold.

Gabelli & Co Investment Advisers first reported a position in NKGNW in Q3 2021 and held it in 13 quarters. The position peaked at $20K in Q4 2021. 3 funds tracked by Wall St. Rank hold NKGNW as of Q1 2025.

  • Gabelli & Co Investment Advisers reported no remaining NKGen Biotech, Inc. Warrants position as of Q1 2025 after selling out during the quarter.
  • Gabelli & Co Investment Advisers sold 17,240 NKGen Biotech, Inc. Warrants shares in Q1 2025, an estimated $1.72K.
  • Gabelli & Co Investment Advisers first reported a position in NKGen Biotech, Inc. Warrants in Q3 2021 and held it in 13 quarters.
  • Gabelli & Co Investment Advisers's NKGen Biotech, Inc. Warrants position peaked at $20K in Q4 2021.
  • 3 funds tracked by Wall St. Rank held NKGen Biotech, Inc. Warrants as of Q1 2025.

Based on Gabelli & Co Investment Advisers's 13F filing for Q1 2025, filed 14 May 2025.